Navigation Links
Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
Date:11/28/2007

SAN CARLOS, Calif., Nov. 28 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) announced today that it is scheduled to present at the upcoming BMO Capital Markets Focus on Healthcare Conference in New York at the Millennium Broadway Hotel on Wednesday, December 5, 2007 at 10:30 a.m. ET.

The presentation and Q&A session will be accessible via a live audio-only Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until December 19, 2007.

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled ten approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.


'/>"/>
SOURCE Nektar Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
2. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
3. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
4. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
5. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
10. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
11. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)...   BioClinica ® , Inc., a specialty ... David Peters , an accomplished senior finance and ... Chief Financial Officer (CFO) and will be joining BioClinica ... than 25 years of financial and accounting experience with ... deep knowledge in all areas of finance, accounting and ...
(Date:6/2/2015)... ST. LOUIS , June 2, 2015 /PRNewswire/ ... leading Life Science and Technology company, announced today ... XCell Science to launch genetically engineered human ... to advance the research of neurological diseases. These ... portfolio, provide unique and versatile tools for the ...
(Date:6/2/2015)... HONG KONG , June 2, 2015 /PRNewswire/ -- China Cord ... "us" and "our"), China,s leading provider ... and stem cell storage services, today announced that the Special ... has appointed Houlihan Lokey ( China ... Steen & Hamilton LLP as its United ...
(Date:6/2/2015)... 2015 GOJO, inventors of PURELL ® ... stewardship at the White House Forum.  GOJO was among ... and stakeholders at the White House Forum to announce ... emergence of antibiotic-resistant bacteria, detect resistant strains, preserve the ... of resistant infections. "A primary prevention approach ...
Breaking Biology Technology:BioClinica Names David Peters New Chief Financial Officer 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 3China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4
... Md. , Feb. 5 Novavax, Inc. (Nasdaq: NVAX ... , President and Chief Executive Officer of Novavax will be presenting at ... 2010 at 10:00 am local time. Hosted by the ... will take place February 8-9 at the Waldorf = ...
... high-grade plastic draws oil out of contaminated water but leaves the ... be squeezed back out for use. , Case Western Reserve ... will effectively clean up spills of all kinds of oils and ... EPA estimates that 10 to 25 million gallons of oil are ...
... , DENVER , Feb. 4 ... employment communities for the hospitality and healthcare industries, are two ... job seekers. , (Photo: http://www.newscom.com/cgi-bin/prnh/20100204/FL49504LOGO-a ) , (Photo: ... Hcareers for the User,s Choice Award three times since WEDDLE,s ...
Cached Biology Technology:NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference 2New material absorbs, conserves oil 2Industry Web Sites Continue to Win Online Award 2Industry Web Sites Continue to Win Online Award 3
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... today announced that members of the executive management team will ... 43rd Annual Technology, Media and Telecom Conference Date: May ... in Boston, MA Cowen ... 2015 Time: 2:45pm ET Location: The New York Palace Hotel, ...
(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a ... established helmet producer, announced today that they will expand ... the world,s first bio-sensing cycling helmet and the first ... in two new colors in order to give cyclists ... product. In addition, LifeBEAM and Lazer announced their plan ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... hybrid laboratory antibodies derived from chimpanzees and humans may ... the serious complications that can occur following smallpox vaccination--and ... The study, led by researchers with the National Institute ... National Institutes of Health (NIH), appears online this week ...
... the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins ... analyzing what many have termed "junk" DNA and identified ... found that these control regions from different species don't ... study will be published online at Science Express March ...
... state-of-the-art anti-aging technologies may extend human lifespans at an ... and economic challenges, says biologist Shripad Tuljapurkar of Stanford ... would have major implications for the global community in ... Professor of Population Studies, will give a talk Feb. ...
Cached Biology News:Mice studies illustrate potential of chimp/human antibodies to protect against smallpox 2Mice studies illustrate potential of chimp/human antibodies to protect against smallpox 3Junk DNA may not be so junky after all 2Junk DNA may not be so junky after all 3World faces challenge as life expectancies lengthen, scientist says 2World faces challenge as life expectancies lengthen, scientist says 3World faces challenge as life expectancies lengthen, scientist says 4
...
Mouse polyclonal antibody raised against a partial recombinant LASS3. NCBI Entrez Gene ID = 204219...
... The ReadyPrep 2-D starter kit is intended ... and ReadyStrip IPG strips. The kit includes a ... and transfer to second-dimension gels six 17 cm, ... IPG strips (ReadyStrip IPG strips and precast SDS-PAGE ...
... is a fully integrated system for fluorescent ... that deliver excellent quality microarray images. The ... microarray scanner that is based on patented ... rejection and spatial resolution. The DNAscope V ...
Biology Products: